A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder.
about
A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A 52-week, double-blind evalua ...... lithium in bipolar I disorder.
@ast
A 52-week, double-blind evalua ...... lithium in bipolar I disorder.
@en
type
label
A 52-week, double-blind evalua ...... lithium in bipolar I disorder.
@ast
A 52-week, double-blind evalua ...... lithium in bipolar I disorder.
@en
prefLabel
A 52-week, double-blind evalua ...... lithium in bipolar I disorder.
@ast
A 52-week, double-blind evalua ...... lithium in bipolar I disorder.
@en
P2093
P2860
P356
P1476
A 52-week, double-blind evalua ...... lithium in bipolar I disorder.
@en
P2093
Berit X Carlson
James M Eudicone
Robert A Forbes
Roger S McIntyre
Ross A Baker
Susan L McElroy
P2860
P356
10.4088/PCC.11M01182
P577
2011-01-01T00:00:00Z